Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • SHEOWS Honors Mothers’ Weekend, Fostering Love and Belonging for Ammas National
  • Akbar Travels Chairman Dr. K.V. Abdul Nazar Honoured with Sheikh Zayed Bin Sultan Al Nahyan Award Lifestyle
  • India needs its own narrative on AI, says filmmaker Shekhar Kapur at MICA pre-summit meet Technology
  • A toxic triple combination of conflict, weather extremes and the economic impact of COVID-19 pandemic risks decades of progress in health and development Press Release
  • Counselor Rima K Women And Child Counselor Most Dignified Lady of Todays World Lifestyle
  • Mulkha Vegala (Extraordinary) Untold Story of uncommon Dr. S. R. Kapse Police Officer Lifestyle
  • 2nd Inter FoodTech Expo To Be Held From 7 – 9 June 2023 At Mumbai India Concurrently With ‘Snack & BakeTec’ And ‘Pac MechEx’ Business
  • Dishman Carbogen Amcis Net Revenue stands at Rs. 541 Crores for Q1 FY23 Business

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • Prestigious Bharat Medical Excellence Award Bestowed Upon Implantologist Dr. Bharat Agravat at Top Doctors Meet Health
  • Partha Dental Makes Invisalign and Partha Aligners More Affordable Than Ever Health
  • Say Hello To A Healthy Heart With The Clinically Tested Properties Of Dabur Honey Health
  • Dr Batra’s® Healthcare Introduces World’s Most Advanced Treatment for Targeted Hereditary Hair Loss: XOGEN Health
  • OMRON Healthcare and Tricog Health strengthen collaboration in India with Tricog CardioCheck (TCC) Health
  • Doctor’s Day Special: Best Cardiologists’ Insights on Heart Attacks in Young Adults & Prevention Health

Recent Posts

  • Shanti Inorganics Limited IPO Opens on Monday, August 31, 2026
  • MBBS in Tripura Through NEET UG 2026: The Quiet Opportunity Most Aspirants Overlook
  • IITM Pravartak Announces Batch 03 of Advanced Certificate in Applied Artificial Intelligence & Deep Learning
  • Apex University’s Udaan 2026 Inspires 3,000 New Students to Embrace Skills, Technology, and Opportunities for a Future-Ready India
  • From Godhra to a Rs 100 Crore Ambition: Parth Derai Builds Blissnack from the Ground Up

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • UltraCare PRO: Your Ultimate Partner In Well-Being Business
  • Raveena Tandon to endorse the brand Garden’s Need, a Leading Manufacturer of planters Business
  • ManavGuru Gears Up to Help Heal Every Disease & Disorder in 9 – 180 Days Press Release
  • Dachepalli Publishers Limited Announces IPO to Strengthen K–12 Educational Publishing and Digital Learning Ecosystem Business
  • AAOMI Makes a Dazzling Debut, Adding a New Pulse to Andheri’s Nightlife Lifestyle
  • Gujarat based co-working player The Address eyeing giant expansion in 2022, all set to triple the existing capacity this year Business
  • QNA Marcom and Events Strengthens APAC Presence with Launch of Mumbai Office Lifestyle
  • Introducing ENCALM PRIVÉ, India’s finest and most exquisite lounge at Delhi International Airport Terminal 3 Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme